GB1051382A - - Google Patents

Info

Publication number
GB1051382A
GB1051382A GB1051382DA GB1051382A GB 1051382 A GB1051382 A GB 1051382A GB 1051382D A GB1051382D A GB 1051382DA GB 1051382 A GB1051382 A GB 1051382A
Authority
GB
United Kingdom
Prior art keywords
red blood
cells
aldehyde
surface active
blood cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Other languages
English (en)
Publication date
Publication of GB1051382A publication Critical patent/GB1051382A/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G01N33/555—Red blood cell
    • G01N33/556—Fixed or stabilised red blood cell
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/25—Reference solutions for assays of biological material containing added polymers to stabilise biological material against degradation or mantain viscosity or density, e.g. gelatin, polyacrylamides, polyvinyl alcohol
    • G01N2496/35—Polyvinylpyrrolidone, e.g. PVP
GB1051382D Expired GB1051382A (da)

Publications (1)

Publication Number Publication Date
GB1051382A true GB1051382A (da) 1900-01-01

Family

ID=1756358

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1051382D Expired GB1051382A (da)

Country Status (1)

Country Link
GB (1) GB1051382A (da)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2408838A1 (fr) * 1977-11-22 1979-06-08 Louderback Allan Sang etalon de controle et procede de sa preparation
FR2884717A1 (fr) * 2005-04-25 2006-10-27 Erytech Pharma Soc Par Actions Erythrocytes renfermant de l'arginine deiminase
US9364504B2 (en) 2007-08-08 2016-06-14 Erytech Pharma Compostition and therapeutic anti-tumour vaccine
US11613759B2 (en) 2015-09-04 2023-03-28 Sqz Biotechnologies Company Intracellular delivery of biomolecules to cells comprising a cell wall

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2408838A1 (fr) * 1977-11-22 1979-06-08 Louderback Allan Sang etalon de controle et procede de sa preparation
FR2884717A1 (fr) * 2005-04-25 2006-10-27 Erytech Pharma Soc Par Actions Erythrocytes renfermant de l'arginine deiminase
US9125876B2 (en) 2005-04-25 2015-09-08 Erytech Pharma Erythrocytes containing arginine deiminase
US9364504B2 (en) 2007-08-08 2016-06-14 Erytech Pharma Compostition and therapeutic anti-tumour vaccine
US9950049B2 (en) 2007-08-08 2018-04-24 Erytech Pharma Composition and therapeutic anti-tumour vaccine
US10780151B2 (en) 2007-08-08 2020-09-22 Erytech Pharma Composition and therapeutic anti-tumour vaccine
US11613759B2 (en) 2015-09-04 2023-03-28 Sqz Biotechnologies Company Intracellular delivery of biomolecules to cells comprising a cell wall

Similar Documents

Publication Publication Date Title
Clemetson et al. High resolution two-dimensional gel electrophoresis of the proteins and glycoproteins of human blood platelets and platelet membranes
Nelsestuen et al. Mode of action of vitamin K. Calcium binding properties of bovine prothrombin
Morrison [10] The determination of the exposed proteins on membranes by the use of lactoperoxidase
Wang et al. Activation of the Ca2+-ATPase of human erythrocyte membrane by an endogenous Ca2+-dependent neutral protease
Stroobant et al. Active transport of calcium in Neurospora plasma membrane vesicles.
Watt et al. Isolation and surface labeling of murine polymorphonuclear neutrophils
Arihara et al. Localization of metmyoglobin-reducing enzyme (NADH-cytochrome b5 reductase) system components in bovine skeletal muscle
Lux et al. Diminished spectrin extraction from ATP-depleted human erythrocytes. Evidence relating spectrin to changes in erythrocyte shape and deformability.
Sasakawa et al. Partition behavior of native proteins in aqueous dextran-poly (ethylene glycol)-phase systems
GB1051382A (da)
Triplett et al. Calcium effects on erythrocyte membrane proteins
Copeland et al. Renaturation and identification of periplasmic proteins in two-dimensional gels of Escherichia coli.
Adunyah et al. Ca2+ transport in human platelet membranes. Kinetics of active transport and passive release.
JPS5823786A (ja) ペルオキシダ−ゼの安定化法
Gellerich et al. Dextran strongly increases the Michaelis constants of oxidative phosphorylation and of mitochondrial creatine kinase in heart mitochondria
Ohnishi et al. Lamprey erythrocytes lack glycoproteins and anion transport
Wilhelm et al. In vitro synthesis of T4 proteins: the products of genes 9, 18, 19, 23, 24, and 38
Izuhara et al. Conformational change of band 3 protein induced by diethyl pyrocarbonate modification in human erythrocyte ghosts
WANGENSTEEN et al. Plasma myocardial depressant activity (shock factor) identified as salt in the cat papillary muscle bioassay system
Wiser et al. Membrane-associated phosphoproteins in Plasmodium berghei-infected murine erythrocytes.
Sinclair et al. Improved retention of heme with increased resolution of microsomal proteins in polyacrylamide gel electrophoresis
Yamaguchi et al. Hemolytic properties under hydrostatic pressure of neuraminidaseor protease-treated human erythrocytes
CA2051350A1 (en) Micro-organism and proteases therefrom
Green et al. The O2− generating oxidoreductase of human neutrophils: Evidence of an obligatory requirement for calcium and magnesium for expression of catalytic activity
Kottel et al. Differential release of membrane-bound alkaline phosphatase isoenzymes from tumor cells by bromelain